CLOS
PFE icon

Compagnie Lombard Odier SCmA’s Pfizer PFE Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.7M Sell
381,061
-5,164
-1% -$137K 0.13% 83
2025
Q4 		$9.62M Buy
386,225
+6,532
+2% +$165K 0.1% 87
2025
Q3 		$9.67M Sell
379,693
-12,725
-3% -$314K 0.11% 88
2025
Q2 		$9.51M Buy
392,418
+23,382
+6% +$545K 0.13% 80
2025
Q1 		$9.35M Hold
369,036
– – 0.11% 88
2024
Q4 		$9.79M Sell
369,036
-16,670
-4% -$452K 0.14% 76
2024
Q3 		$11.2M Sell
385,706
-71,520
-16% -$2.09M 0.17% 73
2024
Q2 		$12.8M Buy
457,226
+77,920
+21% +$2.15M 0.22% 73
2024
Q1 		$10.5M Buy
379,306
+128,651
+51% +$3.57M 0.19% 78
2023
Q4 		$7.22M Buy
250,655
+189,223
+308% +$5.72M 0.13% 88
2023
Q3 		$2.04M Sell
61,432
-31,680
-34% -$1.12M 0.05% 129
2023
Q2 		$3.42M Buy
93,112
+24,967
+37% +$972K 0.1% 94
2023
Q1 		$2.78M Sell
68,145
-4,861
-7% -$210K 0.07% 109
2022
Q4 		$3.74M Buy
73,006
+3,103
+4% +$149K 0.1% 96
2022
Q3 		$3.06M Sell
69,903
-2,165
-3% -$105K 0.09% 89
2022
Q2 		$3.78M Sell
72,068
-2,720
-4% -$139K 0.1% 89
2022
Q1 		$3.87M Sell
74,788
-15,803
-17% -$820K 0.08% 90
2021
Q4 		$5.35M Sell
90,591
-1,476
-2% -$73.1K 0.11% 87
2021
Q3 		$3.97M Sell
92,067
-10,176
-10% -$451K 0.09% 97
2021
Q2 		$4M Buy
102,243
+12,810
+14% +$498K 0.09% 94
2021
Q1 		$3.24M Sell
89,433
-32,187
-26% -$1.14M 0.07% 127
2020
Q4 		$4.48M Buy
121,620
+68,672
+130% +$2.52M 0.12% 82
2020
Q3 		$1.84M Buy
52,948
+12,322
+30% +$432K 0.06% 114
2020
Q2 		$1.26M Sell
40,626
-5,270
-11% -$179K 0.04% 121
2020
Q1 		$1.42M Buy
45,896
+9,726
+27% +$331K 0.06% 111
2019
Q4 		$1.35M Sell
36,170
-1,054
-3% -$37.5K 0.05% 130
2019
Q3 		$1.27M Buy
37,224
+948
+3% +$34.5K 0.05% 126
2019
Q2 		$1.49M Sell
36,276
-1,070
-3% -$42.5K 0.06% 122
2019
Q1 		$1.5M Sell
37,346
-148,305
-80% -$5.94M 0.06% 131
2018
Q4 		$7.69M Sell
185,651
-3,268
-2% -$136K 0.32% 65
2018
Q3 		$7.9M Buy
188,919
+469
+0.2% +$18.1K 0.28% 71
2018
Q2 		$6.49M Sell
188,450
-485
-0.3% -$16.6K 0.24% 77
2018
Q1 		$6.36M Sell
188,935
-200,914
-52% -$6.91M 0.23% 79
2017
Q4 		$13.4M Buy
389,849
+185,569
+91% +$6.33M 0.24% 79
2017
Q3 		$6.92M Sell
204,280
-2,904
-1% -$93.3K 0.25% 80
2017
Q2 		$6.61M Sell
207,184
-7,710
-4% -$243K 0.23% 86
2017
Q1 		$6.97M Sell
214,894
-107,078
-33% -$3.38M 0.24% 81
2016
Q4 		$9.92M Buy
321,972
+5,000
+2% +$153K 0.29% 78
2016
Q3 		$10.2M Sell
316,972
-18,501
-6% -$619K 0.3% 74
2016
Q2 		$11.2M Sell
335,473
-271,448
-45% -$8.66M 0.33% 67
2016
Q1 		$17.1M Sell
606,921
-5,600
-0.9% -$160K 0.52% 44
2015
Q4 		$18.8M Buy
612,521
+113,084
+23% +$3.56M 0.59% 39
2015
Q3 		$14.9M Buy
499,437
+8,402
+2% +$269K 0.61% 38
2015
Q2 		$15.6M Sell
491,035
-12,473
-2% -$407K 0.58% 40
2015
Q1 		$16.6M Buy
503,508
+248,155
+97% +$7.89M 0.63% 37
2014
Q4 		$7.54M Sell
255,353
-57,613
-18% -$1.65M 0.35% 49
2014
Q3 		$8.78M Buy
312,966
+11,896
+4% +$334K 0.35% 46
2014
Q2 		$8.48M Buy
301,070
+12,095
+4% +$345K 0.34% 46
2014
Q1 		$8.81M Sell
288,975
-21,885
-7% -$653K 0.37% 50
2013
Q4 		$9.03M Buy
+310,860
New +$9.05M 0.38% 49

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Compagnie Lombard Odier SCmA's PFE Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA reduced its Pfizer (PFE) stake by 1.3% in Q1 2026, selling an estimated $137K and leaving 381,061 shares worth $10.7M. The position accounts for 0.13% of the portfolio, ranked #83.

Compagnie Lombard Odier SCmA first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $18.8M in Q4 2015. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Compagnie Lombard Odier SCmA held 381,061 shares of Pfizer worth $10.7M as of Q1 2026.
  • Compagnie Lombard Odier SCmA sold 5,164 Pfizer shares in Q1 2026, an estimated $137K.
  • Pfizer made up 0.13% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #83 holding.
  • Compagnie Lombard Odier SCmA first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
  • Compagnie Lombard Odier SCmA's Pfizer position peaked at $18.8M in Q4 2015.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.